Home/Investors/Y Combinator

Y Combinator

Biotech Investor · 14 portfolio companies

Portfolio

14

Focus Areas

17

Top Stage

Pre-clinical

Investment Focus

Oncology Immunology Infectious Disease Endocrine Disorders Type 1 Diabetes Major Depressive Disorder Anxiety Disorders Opioid Use Disorder Psychiatric Diseases Psychiatry Neurology Hematology Kidney disease Regenerative Medicine Disease Modeling

Portfolio Companies

Company	Stage	Valuation	Focus
General Proximity	Pre-clinical	—	Oncology, Immunology
Zeon Systems	—	—	—
Uh-Oh Labs	Commercial	—	Infectious Disease
Isabi	—	—	Oncology
Menten AI	Pre-clinical	—	—
Encellin	Phase 1	—	Endocrine Disorders, Type 1 Diabetes
Gilgamesh Pharmaceuticals	Phase 2	—	Major Depressive Disorder, Anxiety Disorders
Actipulse Neuroscience	Phase 3	—	Psychiatry, Neurology
BrainKey	—	—	Neurology, Psychiatry
Solugen	commercial	—	—
Ditto Biosciences	preclinical	—	Immunology
Velorum Therapeutics	preclinical	—	Oncology, Hematology
Renewal Bio	platform	—	Regenerative Medicine, Disease Modeling
X-Zell	commercial	—	Oncology

Frequent Co-Investors

Johnson & Johnson Innovation1 shared Founders Fund1 shared GIC1 shared Temasek1 shared Khosla Ventures1 shared Two Sigma Ventures1 shared Healthspan Capital1 shared Wilson Sonsini1 shared